GL1X · GenesisL1 explorer

MolNFT v1 · #31881 · protein

Human transthyretin (ttr) complexed with diflunisal analogues- TTR.3', 5'-difluorobiphenyl-4-carboxylic acid

2B9A: “Human transthyretin (ttr) complexed with diflunisal analogues- TTR.3', 5'-difluorobiphenyl-4-carboxylic acid”. X-ray diffraction, 1 ligand (FBC), 1 pocket (best druggability 0.38). MolNFT v1 #31881 on GenesisL1: 3D structure…

PDB
2B9A
Type
protein
Length
223 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
FBC
Pockets
1 · best druggability 0.38

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1086% helix, 53% strandP02766
BTransthyretinprotein1155% helix, 53% strandP02766

Ligands and binding sites

  • FBC · 3',5'-difluorobiphenyl-4-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.380.7817empty

Interfaces

1 interface between chains.

  • A–B · 939 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 2B9A · Human transthyretin (TTR) complexed with diflunisal analogues… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.